Drug Type RNA aptamer |
Synonyms- |
Target |
Mechanism PKR modulators(eukaryotic translation initiation factor 2 alpha kinase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Preclinical | CN | 01 Apr 2024 |